+353-1-416-8900REST OF WORLD
+44-20-3973-8888REST OF WORLD
1-917-300-0470EAST COAST U.S
1-800-526-8630U.S. (TOLL FREE)

Results for tag: "Pazopanib"

Pazopanib Drugs Market - Global Forecast 2025-2030 - Product Thumbnail Image

Pazopanib Drugs Market - Global Forecast 2025-2030

  • Report
  • August 2025
  • 193 Pages
  • Global
From
Pazopanib Generics Market - Global Forecast 2025-2030 - Product Thumbnail Image

Pazopanib Generics Market - Global Forecast 2025-2030

  • Report
  • August 2025
  • 184 Pages
  • Global
From
From
VEGF Inhibitors for Cancer Market - Global Forecast 2025-2030 - Product Thumbnail Image

VEGF Inhibitors for Cancer Market - Global Forecast 2025-2030

  • Report
  • August 2025
  • 185 Pages
  • Global
From
Anti-VEGF Therapy for Cancer Market - Global Forecast 2025-2030 - Product Thumbnail Image

Anti-VEGF Therapy for Cancer Market - Global Forecast 2025-2030

  • Report
  • August 2025
  • 195 Pages
  • Global
From
Kidney Cancer Drugs Market Report 2025 - Product Thumbnail Image

Kidney Cancer Drugs Market Report 2025

  • Report
  • September 2025
  • 250 Pages
  • Global
From
From
Sarcoma Drugs Market Report 2025 - Product Thumbnail Image

Sarcoma Drugs Market Report 2025

  • Report
  • September 2025
  • 250 Pages
  • Global
From
Leiomyosarcoma Drug Global Market Report 2025 - Product Thumbnail Image

Leiomyosarcoma Drug Global Market Report 2025

  • Report
  • July 2025
  • 175 Pages
  • Global
From
From
Soft Tissue Sarcoma Market Report 2025 - Product Thumbnail Image

Soft Tissue Sarcoma Market Report 2025

  • Report
  • February 2025
  • 200 Pages
  • Global
From
From
Gastrointestinal Stromal Tumors - Pipeline Insight, 2025 - Product Thumbnail Image

Gastrointestinal Stromal Tumors - Pipeline Insight, 2025

  • Clinical Trials
  • April 2025
  • 85 Pages
  • Global
From
Renal Cancer - Pipeline Insight, 2025 - Product Thumbnail Image

Renal Cancer - Pipeline Insight, 2025

  • Drug Pipelines
  • April 2025
  • 180 Pages
  • Global
From
From
Sarcoma Therapeutics - Global Strategic Business Report - Product Thumbnail Image

Sarcoma Therapeutics - Global Strategic Business Report

  • Report
  • September 2025
  • 180 Pages
  • Global
From
Soft Tissue Sarcoma - Global Strategic Business Report - Product Thumbnail Image

Soft Tissue Sarcoma - Global Strategic Business Report

  • Report
  • September 2025
  • 282 Pages
  • Global
From
Angiosarcoma Treatment - Global Strategic Business Report - Product Thumbnail Image

Angiosarcoma Treatment - Global Strategic Business Report

  • Report
  • September 2025
  • 390 Pages
  • Global
From
Kidney Cancer Drugs - Global Strategic Business Report - Product Thumbnail Image

Kidney Cancer Drugs - Global Strategic Business Report

  • Report
  • September 2025
  • 148 Pages
  • Global
From
Desmoid Tumors - Global Strategic Business Report - Product Thumbnail Image

Desmoid Tumors - Global Strategic Business Report

  • Report
  • September 2025
  • 286 Pages
  • Global
From
Loading Indicator

Pazopanib is an oncology drug used to treat certain types of cancer. It is a tyrosine kinase inhibitor, meaning it works by blocking the action of certain enzymes that are involved in the growth and spread of cancer cells. Pazopanib is used to treat advanced renal cell carcinoma, a type of kidney cancer, and advanced soft tissue sarcoma, a type of cancer that affects the connective tissues. It is also used to treat other types of cancer, such as ovarian cancer and thyroid cancer. Pazopanib is available in tablet form and is taken orally. It is usually taken once daily, with or without food. Common side effects of pazopanib include nausea, vomiting, diarrhea, fatigue, and hair loss. Some companies in the pazopanib market include GlaxoSmithKline, Novartis, and Pfizer. Show Less Read more